Invention Grant
- Patent Title: Integrin targeted synthetic ligands for diagnostic and therapeutic applications
- Patent Title (中): 整合素靶向合成配体用于诊断和治疗应用
-
Application No.: US14153706Application Date: 2014-01-13
-
Publication No.: US09409951B2Publication Date: 2016-08-09
- Inventor: Luciano Lattuada , Pierfrancesco Morosini , Fulvio Uggeri , Silvio Aime , Enzo Terreno , Daniela Delli Castelli , Carlo Scolastico , Leonardo Manzoni , Daniela Arosio
- Applicant: BRACCO IMAGING S.P.A.
- Applicant Address: IT Milan
- Assignee: BRACCO IMAGING S.P.A.
- Current Assignee: BRACCO IMAGING S.P.A.
- Current Assignee Address: IT Milan
- Agency: Vivicar Law, PLLC
- Priority: ITMI2005A0328 20050303
- Main IPC: C07K7/64
- IPC: C07K7/64 ; C07K5/078 ; C07D401/06 ; C07D471/04
Abstract:
The present invention relates to a novel class of diagnostically or therapeutically effective compounds comprising novel aza-bicycloalkane based cyclic peptides, acting as a targeting moiety towards integrin receptors.
Public/Granted literature
- US20140178302A1 INTEGRIN TARGETED SYNTHETIC LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS Public/Granted day:2014-06-26
Information query
